Anavex Life Sciences Corp.
Símbolo: AVXL
NASDAQ
3.85
USDPrecio de mercado actual
-7.3224
Ratio PER
-2.2699
Ratio PEG
311.23M
Capitalización MRK
- 0.00%
Rendimiento DIV
Anavex Life Sciences Corp. (AVXL) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 603.07 | 151 | 149.2 | 152.1 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 13.16 | 2.7 | 3.2 | 9.1 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 3.22 | 0.7 | 0.4 | 0.4 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 619.45 | 154.4 | 152.7 | 161.6 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.36 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 3.36 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-assets | 8713.08 | 3.4 | 3546.7 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 619.45 | 154.4 | 152.7 | 161.6 | ||||||||||||||||||||
balance-sheet.row.account-payables | 19.05 | 4.3 | 3.8 | 4.7 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 27.39 | 7.3 | 5.9 | 5.6 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 12823.08 | 7.3 | 4.3 | 5.6 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | -12823.08 | -7.3 | -4.3 | -5.6 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-liab | 50.11 | 12.5 | 10.2 | 10.8 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0.33 | 0.1 | 0.1 | 0.1 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -1149.33 | -293.1 | -245.6 | -197.6 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1718.35 | 434.8 | 388 | 348.3 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 569.35 | 141.9 | 142.5 | 150.8 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 619.45 | 154.4 | 152.7 | 161.6 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 569.35 | 141.9 | 142.5 | 150.8 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 619.45 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.net-debt | -603.07 | -151 | -149.2 | -152.1 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -43.16 | -47.5 | -48 | -37.9 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 13.31 | 16.4 | 18.4 | 8.2 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -0.31 | 2.5 | 5.4 | -0.7 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0.55 | 0.5 | 5.9 | -4.3 | ||||||||||||||||||||
cash-flows.row.inventory | -1.53 | -0.5 | -5.9 | 4.3 | ||||||||||||||||||||
cash-flows.row.account-payables | -1 | 0.5 | -0.9 | 0.8 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 1.67 | 2 | 6.3 | -1.5 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0.84 | 0.8 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -29.31 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 27.93 | 27.9 | 21 | 153.2 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 1.52 | 1.8 | 0.3 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 29.45 | 29.7 | 21.3 | 153.2 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0.14 | 1.9 | -2.9 | 122.9 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 603.07 | 151 | 149.2 | 152.1 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 602.93 | 149.2 | 152.1 | 29.2 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -29.31 | -27.8 | -24.2 | -30.4 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -29.31 | -27.8 | -24.2 | -30.4 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 40.33 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.33 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 2.58 | 2.7 | 3.3 | -0.1 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 51.67 | 55.8 | 51 | 41.9 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 51.67 | 55.8 | 51 | 41.9 | ||||||||||||||||||||
income-statement-row.row.interest-income | 7.26 | 6.5 | 0.9 | 0 | ||||||||||||||||||||
income-statement-row.row.interest-expense | -1.13 | 1 | 0.9 | 0 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.83 | 2.7 | 6.8 | 4.3 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 2.58 | 2.7 | 3.3 | -0.1 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.83 | 2.7 | 6.8 | 4.3 | ||||||||||||||||||||
income-statement-row.row.interest-expense | -1.13 | 1 | 0.9 | 0 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2.23 | 0 | 4.3 | 0.2 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | -46.68 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | -48.91 | -47.5 | -54.4 | -41.9 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | -43.04 | -47.5 | -47.6 | -37.6 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0.11 | 0 | 0.4 | 0.3 | ||||||||||||||||||||
income-statement-row.row.net-income | -43.16 | -47.5 | -48 | -37.9 |
Preguntas frecuentes
Cuánto es Anavex Life Sciences Corp. (AVXL) activos totales?
Anavex Life Sciences Corp. (AVXL) los activos totales son 154386000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son N/A.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.000.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -0.357.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.000.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.000.
¿Qué es Anavex Life Sciences Corp. (AVXL) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -47491000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 0.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 55756000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 143765000.000.